Nationally NATIONALLY Recognized Results Standard We Set the STANDARD for Cardiac Surgery Experts We are the Cardiothoracic EXPERTS Best We are the Cardiothoracic EXPERTS

 

We are pleased to announce that ACTS has joined St. Peter’s Health Partners Medical Associates.

SPHPMA is one of the Capital Region’s largest multi-specialty physician groups with more than 850 physicians and advanced practitioners in more than 100 locations.

To learn more about SPHPMA, click here.

 

ABOUT US

Albany Cardiothoracic Surgeons is the oldest heart surgery practice dedicated to cardiothoracic surgery in the Capital District. Our history is a 50-year long tradition of working as a coordinated team to provide expert, high quality, compassionate cardiothoracic surgical care. We serve residents in a broad tri-state area, centered in the Capital District of New York.

Albany Cardiothoracic Surgeons is the exclusive provider of cardiac surgery at St. Peters Hospital in Albany, New York. Our services range from the latest techniques of minimally invasive surgery to the most complex and difficult surgery requiring combinations of traditional and advanced techniques. Our surgical results have surpassed both the state and national standards.

Please see our contact information for office locations and directions.

OUR MISSION

  • We treat all persons with dignity, hospitality and compassion, calling forth their best human potential.
  • We provide comprehensive services that support healthy communities, including quality medical care with holistic approaches to healing body, mind and spirit.
  • We care for and strengthen the ministry and all resources entrusted to us.
  • We advocate for accessible health care and quality of life for all, especially those who are poor.
  • We respond with courage and integrity to needs for services in a rapidly changing health care environment.

LATEST CARDIOLOGY NEWS

(MedPage Today) -- ORLANDO -- Most adults with type 1 diabetes switching from an insulin pump or multiple daily injections to inhaled insulin (Afrezza) needed to increase their dose of the inhaled product to achieve target glycemic control, an...
Posted: May 17, 2025, 6:45 pm
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center...
Posted: May 17, 2025, 6:00 pm
(MedPage Today) -- Outcomes with surgical coronary revascularization were no better with preoperative physiological flow assessments like the fractional flow reserve (FFR), according to a registry study. Measurements of hemodynamic severity before...
Posted: May 16, 2025, 6:41 pm
(MedPage Today) -- ORLANDO -- Fracture risk may be higher after bariatric surgery than after treatment with weight-loss drugs, propensity-score matched data suggested. Among 2,887 matched pairs, adults with obesity who received the GLP-1 receptor...
Posted: May 16, 2025, 4:53 pm
(MedPage Today) -- ORLANDO -- Even type 2 diabetes patients with impaired renal function saw improvements in weight and glycemic control with a dual SGLT1/2 inhibitor, according to a meta-analysis. Among nearly 4,000 adults, those with a baseline...
Posted: May 16, 2025, 2:45 pm